Relative efficacy of neoadjuvant gemcitabine and cisplatin versus methotrexate, vinblastine, adriamycin, and cisplatin in the management for muscle-invasive bladder cancer

Systemic cisplatin-based chemotherapy regimens are the gold standard in advanced bladder cancer. Gemcitabine plus cisplatin (GC) therapy has often been used, although there is no significant evidence that it is better than methotrexate, vinblastine, adriamycin, and cisplatin (MVAC) therapy in neoadj...

Description complète

Détails bibliographiques
Publié dans:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 59(2013), 5 vom: 26. Mai, Seite 277-81
Auteur principal: Kawamura, Norihiko (Auteur)
Autres auteurs: Matsushita, Makoto, Okada, Takayuki, Ujike, Takeshi, Nin, Mikio, Tsujihata, Masao
Format: Article
Langue:Japanese
Publié: 2013
Accès à la collection:Hinyokika kiyo. Acta urologica Japonica
Sujets:Comparative Study English Abstract Journal Article Antibiotics, Antineoplastic Antimetabolites, Antineoplastic Antineoplastic Agents Antineoplastic Agents, Phytogenic Deoxycytidine 0W860991D6 Vinblastine plus... 5V9KLZ54CY Doxorubicin 80168379AG Cisplatin Q20Q21Q62J Methotrexate YL5FZ2Y5U1 Gemcitabine